ETFIQData as of Nov 18, 2026. · etfiq.com/funds/revs

REVS Fact Sheet: Columbia Research Enhanced Value ETF

Share
$33.87
close, Nov 18, 2026

Over the year to Nov 18, 2026, REVS returned +25.2% in total and charged 0.19% a year.

1-year total return
+25.2%
IWB +11.7% to Nov 18, 2026
Expense ratio
0.19%
a year
Net flow, 12 months to Jul 31, 2026
+$206m
monthly N-PORT basis to Jul 31, 2026

Growth of $10,000, 1 year

REVS $12,516 +25.2% · IWB $11,170 +11.7% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+0.1%
3 months−0.5%
Year to date+19.8%
1 year+25.2%
3 years+74.3%
5 years+78.7%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Apple Inc8.00%
Microsoft Corp6.81%
Bank of America Corp3.85%
Chevron Corp2.73%
Altria Group Inc2.23%
Citigroup Inc1.90%
Meta Platforms Inc1.79%
Bristol-Myers Squibb Co1.79%
TJX Cos Inc1.73%
Cisco Systems Inc1.70%

REVS top ten by weight, 32.5% of the fund, of its 303 equity positions, from the holdings filed for Jul 31, 2026.

Facts

Equity fund · Tracks the Beta Advantage Research Enhanced U.S. Value Index · First traded Sep 25, 2019 · Benchmark Russell 1000 Index, measured by IWB, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, REVS Fact Sheet: Columbia Research Enhanced Value ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/revs/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/revs.